Lanean...
A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies with poor prognosis. There are many selectable treatments with good prognosis in Barcelona Clinic Liver Cancer- (BCLC-) 0, A, and B HCC patients, but the most crucial factor affecting survival is the high recurrenc...
Gorde:
| Argitaratua izan da: | Biomed Res Int |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Hindawi
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604585/ https://ncbi.nlm.nih.gov/pubmed/33163533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4037639 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|